1.Russell AJ, Westwood IM, Crawford MH, Robinson J, Kawamura A, Redfield C, Laurieri N, Lowe ED, Davies SG, Sim E.. (2009) Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2., 17 (2):[PMID:19059786][10.1016/j.bmc.2008.11.032]
2.Fan C, Clay MD, Deyholos MK, Vederas JC.. (2010) Exploration of inhibitors for diaminopimelate aminotransferase., 18 (6):[PMID:20185317][10.1016/j.bmc.2010.02.001]
3.Maccari R, Del Corso A, Giglio M, Moschini R, Mura U, Ottanà R.. (2011) In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors., 21 (1):[PMID:21129963][10.1016/j.bmcl.2010.11.041]
4.Bataille CJ, Brennan MB, Byrne S, Davies SG, Durbin M, Fedorov O, Huber KV, Jones AM, Knapp S, Liu G, Nadali A, Quevedo CE, Russell AJ, Walker RG, Westwood R, Wynne GM.. (2017) Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family., 25 (9):[PMID:28341403][10.1016/j.bmc.2017.02.056]